Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorSaigí, Núria
dc.contributor.authorEspelt, Albert
dc.contributor.authorSarasa-Renedo, Ana
dc.contributor.authorCastellano, Yolanda
dc.contributor.authorMajó-Roca, Xavier
dc.contributor.authorCasabona, Jordi
dc.contributor.authorFolch, Cinta
dc.date.accessioned2022-03-09T11:30:04Z
dc.date.available2022-03-09T11:30:04Z
dc.date.issued2014
dc.identifier.citationSaigí N, Espelt A, Folch C, Sarasa-Renedo A, Castellano Y, Majó X, et al. Differences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain). Adicciones. 2014;26(1):69-76.
dc.identifier.issn0214-4840
dc.identifier.urihttps://hdl.handle.net/11351/7125
dc.descriptionHarm reduction programs; Injected drug user; Immigrant; Heroin.
dc.description.abstractThe aims of this study were to describe illegal drug abuse patterns in relation to the migration process and use of drug treatment centers among immigrant injected drug users (IDUs) involved in harm reduction programs, and to compare the characteristics of immigrant and native IDUs. Cross-sectional study of 748 IDUs aged ≥18 years attending harm reduction centers between 2008 and 2009. We explored differences in socio-economic status, illegal drug consumption, health status and use of treatment centers in native versus immigrant IDUs. We also described whether immigrant IDUs started using injected drugs before or after entering the host country. Immigrant IDUs tend to live alone more frequently, start injection at later ages, use heroin and inject it more frequently and use drug treatment centers less frequently than native IDUs. Seventy-six percent of immigrants began using illegal drugs before arriving at the host country. Those who started in other countries were residing in the host country for 5 years or less (63.9%). Overall, immigrant IDUs attended drug treatment centers (36.9%) less frequently than native IDUs (71.8%). In conclusion, migration could be a risk factor for illegal drug abuse initiation or increase in consumption, often with the adoption of local consumption patterns and aggravated due to a lower access to drug treatment centers.
dc.language.isoeng
dc.publisherSocidrogalcohol
dc.relation.ispartofseriesAdicciones;26(1)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectImmigrants
dc.subjectHeroïna - Estudis de casos
dc.subjectDrogoaddicció - Catalunya
dc.subject.meshDrug Users
dc.subject.meshHeroin
dc.subject.meshEmigrants and Immigrants
dc.subject.meshCatalonia
dc.titleDifferences in illegal drug consumption between native and immigrants in a large sample of injected drug users in Catalonia (Spain)
dc.title.alternativeDiferencias en el consumo de drogas ilegales entre nativos e inmigrantes en una amplia muestra de consumidores de droga por vía parenteral en Cataluña (España)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.20882/adicciones.136
dc.subject.decsconsumidores de drogas
dc.subject.decsheroína
dc.subject.decsemigrantes e inmigrantes
dc.subject.decsCataluña
dc.relation.publishversionhttps://doi.org/10.20882/adicciones.136
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Saigí N] Agència de Salut Pública de Barcelona (ASPB), Consorci Sanitari de Barcelona, Generalitat de Catalunya, Barcelona, Spain. [Espelt A] Agència de Salut Pública de Barcelona, Consorci Sanitari de Barcelona, Generalitat de Catalunya, Barcelona, Spain. Institut d’Investigació Biomèdica (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain. CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain. Departament de Psicobiologia i Metodologia de les ciències de la Salut, Universitat Autònoma de Barcelona, Barcelona, Spain. [Folch C] CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain. Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Institut Català d’Oncologia (ICO), Servei Català de la Salut, Generalitat de Catalunya, Barcelona, Spain. Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. [Sarasa-Renedo A] Agència de Salut Pública de Barcelona (ASPB), Consorci Sanitari de Barcelona, Generalitat de Catalunya, Barcelona, Spain. Programa de Epidemiología de campo y epidemiología social (PEAC), Madrid, Spain. [Castellano Y] Agència de Salut Pública de Barcelona (ASPB), Consorci Sanitari de Barcelona, Generalitat de Catalunya, Barcelona, Spain. CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain. [Majó X] Subdirecció General de Drogodependències, Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Casabona J] CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain. Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), Institut Català d’Oncologia (ICO), Servei Català de la Salut, Generalitat de Catalunya, Barcelona, Spain. Departament de Pediatria, d'Obstetrícia i Ginecologia i de Medicina Preventiva, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain
dc.identifier.pmid24652401
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record